Residual Tumor Resection After Anti-PD-1 Therapy: A Promising Treatment Strategy for Overcoming Immune Evasive Phenotype Induced by Anti-PD-1 Therapy in Gastric Cancer

Background: Anti-programmed death 1 receptor (PD-1) therapy is a promising treatment strategy for patients with unresectable advanced or recurrent gastric/gastroesophageal junction (G/GEJ) cancer. However, its response rate and survival benefits are still limited; an immunological analysis of the re...

Повний опис

Бібліографічні деталі

Автори:	Hajime Matsuida, Kosaku Mimura, Shotaro Nakajima, Katsuharu Saito, Sohei Hayashishita, Chiaki Takiguchi, Azuma Nirei, Tomohiro Kikuchi, Hiroyuki Hanayama, Hirokazu Okayama, Motonobu Saito, Tomoyuki Momma, Zenichiro Saze, Koji Kono
Формат:	Artigo
Мова:	Inglês
Опубліковано:	MDPI AG 2025-08-01
Серія:	Cells
Предмети:	anti-PD-1 therapy gastric/gastroesophageal cancer tumor resection tumor immune microenvironment HLA class I TGF-β
Онлайн доступ:	https://www.mdpi.com/2073-4409/14/15/1212
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!